Naringin prevents the structural alterations produced in the small intestine by experimental type 1 Diabetes Mellitus

Diabetic enteropathy is one of the common complications of type 1 Diabetes mellitus (DM1). Naringin (NAR) is a flavonoid with antioxidant, anti-inflammatory and immunomodulatory effects in various tissues. Our objective was to evaluate if NAR prevents the alterations produced in the duodenum,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Talamoni, G, Rivoira , MA, Collin, A, Mukdsi, J, Rodríguez, V
Formato: Artículo revista
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2022
Materias:
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/38978
Aporte de:

Ejemplares similares